Vitamin B12 and folate: the two markers to test together
20 July 2026
Vitamin B12 and folate (vitamin B9) are two blood markers involved in healthy production of red blood cells, synthesis of DNA, and neuronal myelination. Standard blood panels often measure only one of them. Understanding what each one does, and how they interact, helps explain why a result that looks normal can still leave important questions unanswered.
What B12 actually does (and why it needs backup)
Vitamin B12 operates as part of a metabolic team alongside folate (vitamin B9) and vitamin B6. Together, these three vitamins regulate a process called methylation, which is central to how your body synthesizes DNA, manages inflammation, and detoxifies certain compounds.
When one of these vitamins is missing or poorly absorbed, the whole system slows down, and the effects ripple outward in ways that can look like a dozen different conditions.
What deficiency actually feels like
The symptoms of B12 and folate deficiency overlap considerably, and both can develop so gradually that they become part of a person's baseline before they're recognized as something to investigate.
Low B12 first affects the blood and nervous system. As red blood cells grow abnormally large and lose their ability to carry oxygen efficiently (a condition called megaloblastic anemia), fatigue and weakness set in. This is often the first thing people notice, and it's frequently attributed to poor sleep, stress, or a demanding period at work. As deficiency deepens, neurological symptoms emerge: tingling or numbness in the hands and feet, a subtle deterioration in balance and coordination, difficulty concentrating, and memory difficulties. Mood changes are common too: irritability, low mood, and a general flatness that can be mistaken for depression. In severe cases that go uncorrected, nerve damage can become permanent.
Low folate produces a similar pattern of fatigue, irritability, and difficulty concentrating in its early stages. Prolonged deficiency leads to the same megaloblastic anemia. In pregnancy, the consequences are more acute: insufficient folate in the first weeks after conception, often before a woman knows she is pregnant, significantly raises the risk of serious neural tube defects. This is why folate supplementation before and during early pregnancy is recommended across Europe, including in Switzerland.
What makes both of these deficiencies easy to miss is their gradualness. Symptoms accumulate slowly, tend to be non-specific, and are easy to rationalize. A blood test that returns a B12 result in the normal range can reinforce the sense that everything is fine, even when absorption has quietly deteriorated or folate has been borderline for months.
What a B12 result can and can't tell you
A standard B12 test measures the total amount circulating in your blood. It is a useful number, but it is not a direct measure of how much B12 your cells are actually getting, and several things can pull it away from the underlying picture.
Recent supplementation is the most common. B12 levels respond quickly to tablets, injections and fortified foods, so a result taken soon after starting a supplement can look reassuring while stores are still being rebuilt. Inflammation, liver disease and impaired kidney function can also raise B12 artificially, making a result look adequate when it is not.
Absorption is the other blind spot. Normal intake does not guarantee normal uptake: low stomach acid, gastric surgery, long-term use of medications like metformin or proton pump inhibitors, and autoimmune changes affecting intrinsic factor (the protein responsible for absorbing B12 from food) all reduce how much of what you eat actually reaches your bloodstream.
This is why a B12 result is most informative when it is read alongside folate, your symptoms and your risk factors, rather than checked off in isolation.
Folate: the other side of the equation
Folate (B9) works alongside B12 in the methylation cycle, and deficiency in either can produce remarkably similar symptoms: fatigue, difficulty concentrating, irritability, and eventually megaloblastic anemia, where red blood cells grow abnormally large and lose their ability to carry oxygen efficiently.
Your body cannot produce folate. It depends entirely on what you eat (leafy greens, legumes, eggs, liver) and on your capacity to absorb it. Folate blood levels reflect recent dietary intake fairly closely, which is partly what makes them useful and partly what limits them. They can read as adequate in the days after a few good meals, even when the diet has been chronically borderline for months. They can also read as high when supplementation has recently been taken, and a high folate result in isolation says little about long-term adequacy. Both directions of error are possible: a transiently reassuring result after a run of better eating, or an inflated result from recent supplementation that doesn't reflect the prior months. This is why folate levels are most informative when interpreted alongside the other markers in this panel.
In pregnancy, the consequences of inadequate folate are severe. Insufficient folate in the first weeks after conception, often before a woman knows she is pregnant, significantly increases the risk of neural tube defects. This is why folate supplementation before and during early pregnancy is recommended as standard care across the world.
There's also a less commonly known interaction called the folate trap. If folate appears high in your results but B12 is low or borderline, that combination deserves a closer look: it may mean your body has plenty of folate but can't activate it properly because B12 is missing from the reaction. The folate sits unused. In this situation, a high folate result can actually mask the downstream consequences of B12 deficiency, delaying the right diagnosis.
Who is most likely to have low B12?
Several groups are at meaningfully higher risk:
- People following plant-based diets have no reliable dietary source of B12 without supplementation, since B12 occurs naturally only in animal products. Swiss population surveys suggest B12 status varies considerably among vegetarians and vegans, and supplementation is not universal even among those who know the risk.
- Older adults absorb B12 less efficiently as stomach acid production declines with age, even without underlying disease. After 60, dietary intake can stay the same while the amount actually absorbed falls considerably.
- People taking certain medications long-term, including proton pump inhibitors for reflux, metformin for type 2 diabetes or insulin resistance, or some acid-blocking antihistamines, may have impaired B12 absorption without realizing it.
- People with a history of gastric surgery, celiac disease, Crohn's disease, or autoimmune conditions affecting the stomach lining are at structurally higher risk of malabsorption.
There is also a broader group who would not identify with any of the above: people whose dietary intake is adequate but whose absorption has quietly deteriorated, whose symptoms are vague enough to be attributed to stress or poor sleep, and whose standard blood test has come back within the reference range.
What better B12 testing looks like
A genuinely useful B12 assessment doesn't stop at a single number. The most informative approach combines:
| Marker | What it shows |
| Total B12 | Overall circulating B12: useful, though limited in isolation |
| Folate (B9) | Dietary intake and absorption; interacts closely with B12 |
Measured together, these two markers show more than either does alone. They can identify the folate trap, separate a dietary shortfall from an absorption problem, and give you a starting point for tracking whether a change in diet or supplementation is actually working.
How Ahead measures this
Ahead's Essential B-vitamins blood test measures vitamin B12 and folate. It can be added to the Advanced blood test — more than 80 biomarkers covering cardiovascular risk, metabolic function, thyroid health, hormones, and micronutrient status — and is included in the Pro package.
Results are analyzed by Swiss board-certified physicians and delivered as a personalized health report, with context for each finding rather than just a number against a reference range.
Ahead's services complement your GP. If something requires follow-up, the report gives your doctor exactly the data they need to act on it.
Conclusion
Vitamin B12 deficiency is more common than most people assume, and more commonly missed than it should be. A result within the normal range can coexist with poor absorption, with recent supplementation masking a longer shortfall, or with a folate problem sitting underneath. Folate is part of the same metabolic picture, and measuring the two together makes the whole story legible.
Sources
- Herrmann W, Obeid R. Causes and early diagnosis of vitamin B12 deficiency . Deutsches Ärzteblatt International. 2008. PubMed
- Scott JM, Weir DG. The methyl folate trap . The Lancet, 1981; 2(8242):337-40.
- Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency . Mayo Clinic Proceedings, 1994; 69(2):181-6.
- Wang Z et al. B vitamins and prevention of cognitive decline and incident dementia: a systematic review and meta-analysis . Nutrition Reviews, 2022; 80(4):931-949.
- MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study . The Lancet, 1991; 338(8760):131-7.
- Craig WJ. Health effects of vegan diets. American Journal of Clinical Nutrition, 2009; 89(5):1627S-1633S.
- Nilsson-Ehle H. Age-related changes in cobalamin (vitamin B12) handling. Drugs & Aging, 1998; 12(4):277-92.
- European Food Safety Authority (EFSA). Dietary reference values for vitamin B12 . EFSA Journal. 2015. EFSA
- Ryan-Harshman M, Aldoori W. Vitamin B12 and health. Canadian Family Physician, 2008; 54(4):536-41.
- Scaglione F, Panzavolta G. Folate, folic acid and 5-methyltetrahydrofolate are not the same thing . Xenobiotica. 2014. PubMed
Frequently asked questions

Growth Lead
Led commercial and strategy projects in Life Sciences and Global Public Health at McKinsey & Company, including work across commercial due diligence, market access, and growth strategies. Holds a Master's in Banking and Finance from the University of St. Gallen with a focus on data science and quantitative methods.


